Andrew Dickinson
Director Financiero/CFO en GILEAD SCIENCES, INC. .
Fortuna: 9 M $ al 30/04/2024
Perfil
El Sr. Andrew D. Dickinson es presidente, tesorero y director de Immunomedics, Inc., presidente, tesorero y director de Forty Seven, Inc. y director financiero de Gilead Sciences, Inc. Forma parte del Consejo de Administración de Immunomedics, Inc., Forty Seven, Inc., Fosun Kite Biotechnology Co., Ltd. y Gilead Sciences Ltd. Anteriormente, el Sr. Dickinson fue socio fundador de Kendall Dickinson & Koenig LLC, secretario, vicepresidente y consejero general de Myogen, Inc. y codirector de la banca de inversión sanitaria de Lazard Ltd. Se licenció en la Universidad de Colorado y se graduó en la Universidad Loyola de Chicago.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GILEAD SCIENCES, INC.
0.01% | 10/03/2024 | 134 983 ( 0.01% ) | 9 M $ | 30/04/2024 |
Cargos activos de Andrew Dickinson
| Empresas | Cargo | Inicio |
|---|---|---|
| GILEAD SCIENCES, INC. | Director Financiero/CFO | 01/11/2019 |
| FORTY SEVEN, INC. | Presidente | 07/04/2020 |
| IMMUNOMEDICS, INC. | Presidente | 23/10/2020 |
| GALAPAGOS NV | Director/Miembro de la Junta | 27/03/2024 |
| CYMABAY THERAPEUTICS, INC. | Presidente | 21/03/2024 |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The company is based in London, UK and specializes in the distribution of pharmaceutical products. | Director/Miembro de la Junta | 31/10/2019 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Director/Miembro de la Junta | - |
Sutter Health
 Sutter Health Medical/Nursing ServicesHealth Services Sutter Health engages in the provision of healthcare services. It offers allergy care, asthma care, gastroenterology, imaging, liver care, occupational health, pediatric, bioethics, dermatology, emergency, back and spine, heart and vascular, cancer, and fertility services. The company was founded in January 1996 and is headquartered in Sacramento, CA. | Director/Miembro de la Junta | 01/08/2021 |
Antiguos cargos conocidos de Andrew Dickinson.
| Empresas | Cargo | Fin |
|---|---|---|
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Consejero General | 17/11/2006 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de Andrew Dickinson.
| Loyola University of Chicago | Graduate Degree |
| The University of Colorado | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| LAZARD, INC. | Finance |
| GALAPAGOS NV | Health Technology |
| Empresas privadas | 8 |
|---|---|
Kendall Dickinson & Koenig LLC
 Kendall Dickinson & Koenig LLC Miscellaneous Commercial ServicesCommercial Services Kendall Dickinson & Koenig LLC provides legal services. The private company is based in Denver, CO. | Commercial Services |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
Gilead Sciences Ltd.
Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The company is based in London, UK and specializes in the distribution of pharmaceutical products. | Distribution Services |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Sutter Health
Sutter Health Medical/Nursing ServicesHealth Services Sutter Health engages in the provision of healthcare services. It offers allergy care, asthma care, gastroenterology, imaging, liver care, occupational health, pediatric, bioethics, dermatology, emergency, back and spine, heart and vascular, cancer, and fertility services. The company was founded in January 1996 and is headquartered in Sacramento, CA. | Health Services |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Dickinson
